Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
 
Ketamine Elicits Brain State Resembling Early Stages of Schizophrenia
26 August 2014. Blocking glutamate receptors with ketamine produces a state of hyperconnectivity in the prefrontal cortex that most resembles that found in early stages of schizophrenia...
 
SIRS 2014—Connecting Clinical and Preclinical Research
22 August 2014. The April 7 SIRS 2014 plenary session focused on three aspects of schizophrenia symptoms: psychosis, motivation, and social cognition...
 
Stem Cells and TALENs Bring DISC1 Back in the News
18 August 2014. DISC1 returns to center stage, thanks to a marriage of stem cell and DNA editing technologies...
 
 
 
 
Spotlight

DISC1 iPS Cell Paper Evokes Discussion
The recent publication in Nature of a paper describing induced pluripotent stem cells from mental illness patients who have mutations in the gene DISC1 has generated interest. Read comments by Kristen Brennand, Carsten Korth, Nick Brandon, and Atsushi Kamiya, and contribute your own thoughts.
Schizophrenia Researchers Convene at SIRS Meeting
Some 1,600 researchers and clinicians gathered amidst the public art of Florence, Italy, to discuss the latest in schizophrenia research at the Schizophrenia International Research Society Conference (SIRS) meeting. Discussions ranged from possible links between psychosis and different types
of infections to broadening the definition of "schizophrenia." We have now posted all of our reports from these sessions. Image courtesy of Wikimedia See also Allison Curley's photos from the Firenze Fiera Congress Center.
Drugs in Trials Compendium Updated
Hugo Geerts
This week, Hugo Geerts weighs in with his semiannual update on clinical trials for schizophrenia. Amid many disappointing results, there are a few compounds that have made progress: Intra-Cellular Therapeutics's ITI-007 and Reviva's RP5063, both of which have dopaminergic as well as serotonergic targets and had successful Phase 2 proof-of-concept trials. Other updates are for EGIS-11150, BFF-816, AZD2624, Org25925, F17464, F17807, AE58054, MP-10, bitopertin, TC5619, DAR-100, NW3509, and AUT6.
Welcome to the Schizophrenia Research Forum!
Welcome to the Schizophrenia Research Forum website—a virtual community for science about schizophrenia and related disorders. Our Mission is to help researchers in their quest for causes, improved treatments, and better understanding of schizophrenia. Read more about ways to browse the site.
 
What's New

Comments - Posted 26 August 2014
Read remarks by Hugo Geerts about Anticevic A et al.
NEWS: Ketamine Elicits Brain State Resembling Early Stages of Schizophrenia
 
Comments - Posted 26 August 2014
Read remarks by Alexandre Seillier about Metaxas A et al.
PAPER: Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
 
Comments - Posted 25 August 2014
Read remarks by Atsushi Kamiya about Wen Z et al.
NEWS: Stem Cells and TALENs Bring DISC1 Back in the News
 
Conferences - Posted 24 August 2014
Winter Conference on Brain Research: 24-29 January 2015, Big Sky, MT, U.S.A.
 
Comments - Posted 22 August 2014
Read remarks by Barbara K. Lipska about Jan-Harry Cabungcal et al.
NEWS: Model of Schizophrenia Cortical Deficits Reversed With Antioxidants
 
Jobs - Posted 19 August 2014
Junior Faculty Position in Vision Research in Schizophrenia: Rutgers Biomedical and Health Sciences, Piscataway, New Jersey.
August 27, 2014
SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark

Check out our Schizophrenia Bulletin Forum Discussion: Prefrontal Inefficiency Is Associated With Polygenic Risk for Schizophrenia.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.
SZGene
AlzGene
MSGene
PDGene
An up-to-date collection of all published genetic association studies.
A community resource created by Jim Koenig, University of Maryland.
We invite your comments and suggested edits to these facts about schizophrenia.
Compiled by Angus MacDonald, S. Charles Schulz, and the Minnesota Consensus Group.
CC Grand Rounds: Contemporary Issues in Graduate Medical Education: Better Handoffs, Safer Care: Improving Transitions of Care to Reduce Medical Errors and Improve Patient Safety: Wednesday, August 27, 2014, 12:00 p.m.

Neuroimmune Mechanisms Contributing to Addiction Neurobiology: Tuesday, September 02, 2014, 8:30 a.m.

National Advisory Neurological Disorders and Stroke Council Meeting—September 2014: Thursday, September 11, 2014, 8:00 a.m.

Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright